We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
World - Antisera And Other Blood Fractions - Market Analysis, Forecast, Size, Trends and Insights
Report Update: Jan 1, 2025

World - Antisera And Other Blood Fractions - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing
Jun 26, 2018

Switzerland and Germany are Main Suppliers on the Global Antisera Market

IndexBox has just published a new report "World: Antisera And Other Blood Fractions - Market Report. Analysis and Forecast to 2025". Here is a summary of the report's key findings.

Global Consumption of Antisera Reached $X Billion

In 2016, the antisera and other blood fractions market grew by X% to X billion USD. According to the IndexBox estimates, from 2007 to 2016 the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries.

In the immediate term, global antisera consumption is expected to retain its upward trend pattern, driven primarily by an increase of consumption in Asia region, where public health spending is expanding along with robust economy growth. On the other hand, some poor countries which need antisera as they suffer heavily from snake bites and envenoming, can't afford it due to health budget shortages. Such countries, especially in Africa and Latin America, indicate significant market demand, which, however is limited by only a modest economy growth and potential.

The U.S. and India Were the Main Consuming Countries of Antisera

In 2016, the countries with the highest consumption were the U.S. (X billion USD) and India (X billion USD), together comprising near X% of global consumption. The other countries lagged far behind in terms of antisera consumption: Japan (X billion USD), with X% of total consumption, China (X%), the U.K. (X%), France (X%) and Canada (X%).

The highest annual growth rates of antisera and other blood fractions consumption from 2007 to 2016 were recorded in India, with +X% growth, China, with +X%, France, with +X% and Japan, with +X% growth. Following these rapid consumption growth rates, India significantly strengthened its share in terms of the global consumption from X% in 2007 to X% in 2016. China increased its share of consumption by +X percentage points, Japan (+X percentage points) and France (+X percentage points) also increased their shares. By contrast, the share of the U.S. declined from X% to X% over the period under review.

Amongst the leading consuming countries, high levels of per capita consumption levels were recorded in the U.S. (X USD/year in 2016) and Canada (X USD/year), which were significantly higher than the world average of X USD/year. In these countries per capita consumption grew by +X% and +X%, respectively from 2007-2016. The annual growth of per capita consumption over the last nine years was the most notable in India, with +X% growth, China, with +X% growth, France, with +X% growth, Japan, with +X% growth.

Antisera Production Value Doubled over the Last Nine Years, Amounting to X billion USD

Production of antisera and other blood fractions reached X billion USD in 2016, expanding steadily from 2007 to 2016. Overall, the production value doubled from the level of 2007, rising on awerage by +X% per year over that period.

The U.S., Switzerland and India Were the Leading Producers of Antisera

The U.S. (X billion USD), Switzerland (X billion USD) and India (X billion USD) were the key world antisera and other blood fractions producing countries, together making up X% of global output in 2016.

From 2007 to 2016, in Switzerland and the U.S. production levels increased by +X% and +X% per year, respectively, largely attributed to both strong domestic and global demand.

In India, production of antisera and other blood fractions was not observed before 2011, however, over the period from 2011 to 2016, it grew from X billion USD to X billion USD, with a CAGR of +X per year.

Antisera Remains a Highly Traded Global Commodity

Antisera and other blood fractions is a worldwide traded commodity with high trade intensity, determined mainly the substantial distance of many of the consumer countries from the centers of antisera production. In some of the consumer countries, the level of technological and economic development is insufficient for the production of antisera.

Antisera and other blood fractions will continue to be highly traded, however, in the medium term, annual growth will slow due to softening growth of antisera production.

Switzerland and Germany Were Main Suppliers of Antisera

In 2016, Switzerland (X billion USD) and Germany (X billion USD) were the main global suppliers of antisera and other blood fractions, with a combined share of X% of global exports in value terms. They were followed by the U.S. (X%), the Netherlands (X%), Belgium (X%), Ireland and the U.K. (X% each).

Ireland (+X% per year) and the U.K. (+X% per year) were among the fastest growing suppliers from 2007 to 2016. The remaining exporting countries also showed positive dynamics.

Ireland (+X percentage point) and the UK (+X percentage point) strengthened their positions in terms of the global export, while the shares sent from the U.S. (-X percentage point), Germany (-X percentage point), the Netherlands (-X percentage point) and Switzerland (-X percentage point) illustrated negative dynamics. The share of Belgium remained relatively stable throughout the analyzed period.

Do you want to know more about the global antisera market? Get the latest trends and insight from our report. It includes a wide range of statistics on

  • antisera market share
  • antisera prices
  • antisera industry
  • antisera sales
  • antisera import
  • antisera export
  • antisera market forecast
  • antisera price forecast
  • key antisera producers

Source: IndexBox Market Intelligence Platform

This report provides an in-depth analysis of the global antisera market. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21202125 - Antisera, other immunological products which are directly involved in the regulation of immunological processes and other blood fractions

Country coverage:

Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries:

+ the largest producing countries

Data coverage:

  • Global market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Global production, split by region and country
  • Global trade (exports and imports)
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Company coverage:

Charles River, Cruinn Diagnostics, SSI Diagnostica, Kyowa Kirin, HyTest, Athens Research and Technology, Antibodies, Biocell Laboratories, Accurate Chemical & Scientific Corporation, Aldon Corporation, List Biological Laboratories, Lee Laboratories, H.D.M. Labs, Research Plus, Capra Science Antibodies, Sartorius, Octapharma, Blood Centers of America, MPbio, Monobind, Quotient, Abcam, Bio-Rad

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. GLOBAL PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY

  8. 8. GLOBAL IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2024
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. GLOBAL EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2024
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • United States
    • China
    • Japan
    • Germany
    • United Kingdom
    • France
    • Brazil
    • Italy
    • Russian Federation
    • India
    • Canada
    • Australia
    • Republic of Korea
    • Spain
    • Mexico
    • Indonesia
    • Netherlands
    • Turkey
    • Saudi Arabia
    • Switzerland
    • Sweden
    • Nigeria
    • Poland
    • Belgium
    • Argentina
    • Norway
    • Austria
    • Thailand
    • United Arab Emirates
    • Colombia
    • Denmark
    • South Africa
    • Malaysia
    • Israel
    • Singapore
    • Egypt
    • Philippines
    • Finland
    • Chile
    • Ireland
    • Pakistan
    • Greece
    • Portugal
    • Kazakhstan
    • Algeria
    • Czech Republic
    • Qatar
    • Peru
    • Romania
    • Vietnam

  12. LIST OF TABLES

    1. Key Findings In 2024
    2. Market Volume, In Physical Terms, 2012–2024
    3. Market Value, 2012–2024
    4. Per Capita Consumption, By Country, 2018–2024
    5. Production, In Physical Terms, By Country, 2012–2024
    6. Imports, In Physical Terms, By Country, 2012–2024
    7. Imports, In Value Terms, By Country, 2012–2024
    8. Import Prices, By Country Of Destination, 2012–2024
    9. Exports, In Physical Terms, By Country, 2012–2024
    10. Exports, In Value Terms, By Country, 2012–2024
    11. Export Prices, By Country Of Origin, 2012–2024

  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2024
    2. Market Value, 2012–2024
    3. Consumption, By Country, 2024
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2024
    18. Production, In Value Terms, 2012–2024
    19. Production, By Country, 2024
    20. Production, In Physical Terms, By Country, 2012–2024
    21. Imports, In Physical Terms, 2012–2024
    22. Imports, In Value Terms, 2012–2024
    23. Imports, In Physical Terms, By Country, 2024
    24. Imports, In Physical Terms, By Country, 2012–2024
    25. Imports, In Value Terms, By Country, 2012–2024
    26. Import Prices, By Country, 2012–2024
    27. Exports, In Physical Terms, 2012–2024
    28. Exports, In Value Terms, 2012–2024
    29. Exports, In Physical Terms, By Country, 2024
    30. Exports, In Physical Terms, By Country, 2012–2024
    31. Exports, In Value Terms, By Country, 2012–2024
    32. Export Prices, 2012–2024

Recommended posts

Free Data: Antisera And Other Blood Fractions - World
Table
Antisera And Other Blood Fractions - World - Table
Dashboard
Antisera And Other Blood Fractions - World - Dashboard
Report
Antisera And Other Blood Fractions - World - Report